Texas A&M Health

Researchers are shifting the focus from late-stage Alzheimer’s to the earlier biological transition when mild cognitive impairment begins converting to dementia.

Study shows how a cell-signaling receptor helps prostate cancer cells accumulate cholesterol, a process linked to tumor growth and treatment resistance.

The 18th annual Disaster Day training exercise added a bioterrorism element to prepare the next generation of health professionals for real-world challenges.

Building on previous findings, researchers are exploring how desynchronized circadian rhythms may trigger brain inflammation associated with dementia risk.

The discovery reveals a novel non-coding RNA that preserves cellular structures and may guide new therapies for multiple myeloma and leukemia.

An expert gives guidance on what watches, rings and bands can (and can’t) do for your wellness at home and in the clinic.

Texas A&M researchers are combining a common ingredient with high-level medical technology to find new treatments to long-term conditions.

Mental health experts offer strategies for overcoming the holiday blues.

Texas A&M Health researcher explores how epigenetics link parents’ habits to long-term health outcomes in their children.

Researchers have created tools that respond to blue light with pinpoint accuracy, potentially revolutionizing cell therapy, cancer treatment and precision medicine.